Phenotype and biochemical heterogeneity in late onset Fabry disease defined by <i>N215S</i> mutation - Fig 4

<p>Correlation analyses: (1) Plasma globotriaosylsphingosine (Lyso-Gb3) and plasma α-Gal A activity for males <i>N215S</i> (A; n = 13), males <i>non-N215S</i> (B; n = 9), females <i>N215S</i> (C; n = 25), and females <i>non-N215S</i> (D; n = 36). (2) Age adjusted severity score (AAS) and plasma α-Gal A activity for males <i>N215S</i> (E; n = 36), males <i>non-N215S</i> (F; n = 48), females <i>N215S</i> (G; n = 45), and females <i>non-N215S</i> (H; n = 98); ns = not significant.